STOCK TITAN

VisionSys AI Inc 424B Filings

VSA NASDAQ

Every 424B that VisionSys AI Inc (VSA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow VSA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VSA filings page.

Rhea-AI Summary

VisionSys AI Inc is offering 6,000,000 ADSs (each ADS at $1.00), representing 1,500,000,000 Class A ordinary shares pursuant to a securities purchase agreement and placement agency agreement. The offering's gross proceeds are $6.0 million; net proceeds to the company are estimated at approximately $5.58 million after placement agent fees and estimated expenses. The ADSs trade on Nasdaq under the symbol VSA. The company intends to use net proceeds for general corporate purposes and working capital. The placement agent fee is 7% of gross proceeds and a 1.0% non-accountable expense reimbursement.

Rhea-AI Summary

VisionSys AI Inc is offering 250,000 ADSs, 2,750,000 pre-funded warrants in lieu of ADSs and 2,750,000 ADSs underlying those warrants, representing 750,000,000 Class A ordinary shares, pursuant to a securities purchase agreement and placement agency agreement.

The purchase price per ADS is $1.00; each Pre-Funded Warrant is exercisable immediately at $0.0001 per ADS. The ADSs represent 250 Class A ordinary shares each and trade on Nasdaq under the symbol VSA. The company expects net proceeds of approximately $2.5 million to be used for general corporate purposes and working capital, after placement agent fees and expenses.

Rhea-AI Summary

VisionSys AI Inc. launched a primary offering of 9,230,750 American Depositary Shares (ADSs) with accompanying Series A Warrants at $1.30 per ADS-and-warrant unit. Gross proceeds are $11,999,975, with a 6% placement fee of $719,998.50; the company estimates net proceeds of about $10.96 million for general corporate purposes and working capital. This supplement also covers up to 9,415,365 ADSs issuable upon exercise of the Series A and Placement Agent Warrants.

The Series A Warrants are immediately exercisable at $1.30 per ADS for five years, with reset prices to $0.91 on the 4th trading day and $0.65 on the 8th trading day after issuance, plus proportional ADS increases. A zero-cash exercise feature can deliver 3.0x the cash-exercise ADSs (2.0x for Placement Agent Warrants), likely yielding no additional cash to the issuer on exercise. ADSs outstanding rise from 9,486,415 to 18,717,165 post-offering (no warrant exercise). The ADSs trade on Nasdaq as “VSA” (last sale $1.30); the Warrants will not be listed. Insiders are subject to a 120-day lock-up; the company agreed to a 20-day standstill.